APA (7th ed.) Citation

Wakabayashi, H., Arita, M., Mori, T., Ito, H., Miyoshi, T., Naoe, S., . . . Kanda, S. (2023). Enhanced Production of EPA-Derived Anti-Inflammatory Metabolites after Oral Administration of a Novel Self-Emulsifying Highly Purified EPA Ethyl Ester Formulation (MND-2119). Journal of Atherosclerosis and Thrombosis, 30(12), 1927-1949. https://doi.org/10.5551/jat.64135

Chicago Style (17th ed.) Citation

Wakabayashi, Hiroyuki, Makoto Arita, Takuya Mori, Hiroshi Ito, Toru Miyoshi, Satoko Naoe, Takashi Yano, and Shingo Kanda. "Enhanced Production of EPA-Derived Anti-Inflammatory Metabolites After Oral Administration of a Novel Self-Emulsifying Highly Purified EPA Ethyl Ester Formulation (MND-2119)." Journal of Atherosclerosis and Thrombosis 30, no. 12 (2023): 1927-1949. https://doi.org/10.5551/jat.64135.

MLA (9th ed.) Citation

Wakabayashi, Hiroyuki, et al. "Enhanced Production of EPA-Derived Anti-Inflammatory Metabolites After Oral Administration of a Novel Self-Emulsifying Highly Purified EPA Ethyl Ester Formulation (MND-2119)." Journal of Atherosclerosis and Thrombosis, vol. 30, no. 12, 2023, pp. 1927-1949, https://doi.org/10.5551/jat.64135.